More than six in 10 patients with a complicated stage of a common sort of pores and skin most cancers saw their tumors nearly

 or absolutely disappear while treated with immunotherapy before surgical procedure -- effects likely to exchange how physicians target those cancers.

That's in line with the University of Texas MD Anderson Cancer Center,

 which said the findings Monday on the European Society for Medical Oncology Congress 2022 in Paris.

Each year, about 1 million people in the United States are diagnosed with squamous cell carcinoma of the skin

According to the news release, the studies crew stated it's going to maintain to follow the study

 members and hopes to deal with nevertheless-unanswered questions on the most fulfilling range of doses before surgery.

Gross said he was "excited to see how this new treatment approach impacts outcomes, including quality of life, as we continue long-term